-
1 Comment
Austco Healthcare Limited is currently in a long term uptrend where the price is trading 55.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Austco Healthcare Limited's total revenue sank by 12.9% to $15M since the same quarter in the previous year.
Its net income has increased by 2.1% to $826K since the same quarter in the previous year.
Finally, its free cash flow fell by 58.2% to $98K since the same quarter in the previous year.
Based on the above factors, Austco Healthcare Limited gets an overall score of 3/5.
| ISIN | AU0000120818 |
|---|---|
| Industry | Medical Instruments & Supplies |
| Exchange | AU |
| CurrencyCode | AUD |
| Sector | Healthcare |
| Market Cap | 126M |
|---|---|
| PE Ratio | 17.25 |
| Target Price | 0.5 |
| Beta | 0.25 |
| Dividend Yield | None |
Austco Healthcare Limited, together with its subsidiaries, engages in the business of development, manufacture, service, supply, and distribution of healthcare communications equipment and software in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP nurse call system; Medicom, a solution for nurse call system; Pulse Mobile which allows staff to manage nurse call functions on the go and trigger workflows remotely; clinical workflow that allows healthcare staff to communicate with ancillary departments, measure adherence to protocol, and control other systems; Built-in RTLS, a nurse call platform; enterprise reporting; and integration services. It is also involved in the marketing, sales, and installation of electronic healthcare communication systems. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020. Austco Healthcare Limited was founded in 1986 and is headquartered in Port Melbourne, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AHC.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
